Wednesday, February 10, 2010, 12:53am EST - Canadian Markets open in 8 hours and 37 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ViroPharma Inc. (VPHM)

 On Feb 9: 9.74 USD  Up 0.35 (3.73%)  
MORE ON VPHM
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ViroPharma Incorporated (NasdaqNM:VPHM) Delayed quote dataEdit
After Hours: 9.39 Down 0.35 (3.59%) as of 5:00pm EST on 02/09/10
Last Trade: 9.74 USD
Trade Time: Feb 9
Change: Up 0.35 (3.73%)
Prev Close: 9.39
Open: 9.42
Bid: 8.53 x 100
Ask: 10.26 x 100
1y Target Est: 11.30
Day's Range: 9.32 - 9.80
52wk Range: 3.79 - 10.74
Volume: 911,666
Avg Vol (3m): 976,435
Market Cap: 754.29M
P/E (ttm): N/A
EPS (ttm): -0.27
Div & Yield: N/A (N/A%)
ViroPharma Inc. (VPHM)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add VPHM to Portfolio   Download Data

HEADLINES
• Optimer Pharma rises on fidaxomicin study data
AP (Fri, Feb 5)
• The Next Million-Dollar Penny Stock
at Motley Fool (Wed, Jan 20)
• ViroPharma expands licensing deal for angioedema drug Cinryze
at bizjournals.com (Mon, Jan 11)
• Biotech News on Cusp of J.P. Morgan Confab: BioBuzz
at TheStreet.com (Mon, Jan 11)
• VIROPHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Mon, Jan 11)
• ViroPharma Provides 2010 Cinryze(TM) (C1 Esterase Inhibitor [Human]) Outlook
PRNewswire (Mon, Jan 11)
• ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])
PRNewswire (Mon, Jan 11)
• VIROPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Jan 8)
• ViroPharma to Participate in the 28th Annual J.P. Morgan Healthcare Conference
PRNewswire (Wed, Jan 6)
• The FDA (Still) Hates Antibiotic Makers
at Motley Fool (Thu, Dec 31)
More Headlines for VPHM...
ANALYST
EPS Est (next year) (Dec-09) : -0.05
EPS Est (in 2 years) (Dec-10) : 0.25
Avg Rec (current)*: 1.9
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases with a focus on products used by physician specialists or in hospital settings in the United States an...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices